Beyond PACIFIC: Real-World Outcomes of Adjuvant Durvalumab According to Treatment Received and PD-L1 Expression

Denault, MH; Feng, JM; Kuang, SL; Shokoohi, A; Leung, B; Liu, MT; Berthelet, E; Laskin, J; Sun, SP; Zhang, TA; Ho, CRY; Melosky, B

Melosky, B (通讯作者)，Vancouver Ctr, BC Canc, 600 West 10th Ave, Vancouver, BC V5Z 4E6, Canada.

CURRENT ONCOLOGY, 2023; 30 (8): 7499

Abstract

Adjuvant durvalumab after chemoradiotherapy (CRT) is the standard of care for unresectable stage III non-small cell lung cancer (NSCLC). A post hoc ex......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索